Table 1 Correlation between C14orf166 expression and clinicopathologic characteristics of breast cancer patient
From: C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
Characteristics | Total | C14orf166 | Chi-square test p value | ||
|---|---|---|---|---|---|
Low expression | High expression | ||||
Age (years) | |||||
 <40 | 27 | 12 | 15 | 0.424 | |
 ≥40 | 94 | 46 | 48 | ||
Clinical stage | |||||
 I | 15 | 13 | 2 | <0.001 | |
 II | 55 | 31 | 24 | ||
 III | 34 | 11 | 23 | ||
 IV | 17 | 3 | 14 | ||
T classification | Â | ||||
 T1 | 26 | 17 | 9 | <0.01 | |
 T2 | 65 | 34 | 31 | ||
 T3 | 23 | 6 | 17 | ||
 T4 | 7 | 1 | 6 | ||
N classification | Â | ||||
 0 | 45 | 33 | 21 | <0.001 | |
 1 | 48 | 18 | 30 | ||
 2 | 25 | 6 | 19 | ||
 3 | 3 | 1 | 2 | ||
M classification | |||||
 Yes | 6 | 0 | 6 | 0.018 | |
 No | 115 | 58 | 57 | ||
ER | |||||
 0 | 51 | 23 | 28 | 0.325 | |
 1 | 58 | 28 | 30 | ||
 2 | 9 | 4 | 5 | ||
 3 | 3 | 3 | 0 | ||
PR | |||||
 0 | 49 | 18 | 31 | 0.02 | |
 1 | 60 | 30 | 30 | ||
 2 | 10 | 9 | 1 | ||
 3 | 1 | 0 | 1 | ||
 4 | 1 | 1 | 0 | ||
Vital status (at follow-up) | |||||
 Alive | 64 | 51 | 13 | <0.001 | |
 Dead | 57 | 7 | 50 | ||